Published in Am J Public Health on February 01, 1987
Stanford Five-City Multifactor Risk Reduction Study | NCT00005143
Comparative evaluation of American Cancer Society and American Lung Association smoking cessation clinics. Am J Public Health (1990) 2.55
The future of community-based cardiovascular disease intervention studies. Am J Public Health (1994) 1.90
Television and health education: stay tuned. Am J Public Health (1987) 1.39
Evaluation of a minimal-contact smoking cessation intervention in an outpatient setting. Am J Public Health (1987) 1.32
Coeur en santé St-Henri--a heart health promotion programme in a low income, low education neighbourhood in Montreal, Canada: theoretical model and early field experience. J Epidemiol Community Health (1995) 1.10
Smokers' challenge: immediate and long-term findings of a community smoking cessation contest. Am J Public Health (1987) 1.05
Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden. J Epidemiol Community Health (1996) 0.92
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence. Tob Use Insights (2015) 0.89
Quit and Win campaigns as a long-term anti-smoking intervention in North Karelia and other parts of Finland. Tob Control (1999) 0.86
International Quit and Win 1996: comparative evaluation study in China and Finland. Tob Control (2000) 0.82
Cost effectiveness of a community based research project to help women quit smoking. Tob Control (2005) 0.82
Nicotine dependence and cost-effectiveness of individualized support for smoking cessation: evidence from practice at a worksite in Japan. PLoS One (2013) 0.81
A comparison of cessation counseling received by current smokers at US dentist and physician offices during 2010-2011. Am J Public Health (2014) 0.75
University-Based Smoking Cessation Program Through Pharmacist-Physician Initiative: An Economic Evaluation. J Clin Diagn Res (2016) 0.75
How physicians can help their patients quit smoking. A practical guide. West J Med (1988) 0.75
The Stanford Five-City Project: design and methods. Am J Epidemiol (1985) 4.06
A framework for evaluating community-based heart disease prevention programs. Soc Sci Med (1986) 1.45
Assessing the cost-effectiveness of prevention. J Community Health (1983) 1.40
Mediated smoking cessation programs in the Stanford Five-City Project. Addict Behav (1985) 1.14
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
Measuring agreement in method comparison studies. Stat Methods Med Res (1999) 31.11
Multiple significance tests: the Bonferroni method. BMJ (1995) 23.46
Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65
Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) (1986) 18.51
Analysis of serial measurements in medical research. BMJ (1990) 16.69
Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health (1992) 15.38
Cronbach's alpha. BMJ (1997) 13.79
The scandal of poor medical research. BMJ (1994) 11.58
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med (2001) 11.48
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Statistics notes. Logarithms. BMJ (1996) 10.56
Statistics in medical journals. Stat Med (1983) 9.80
Evaluating non-randomised intervention studies. Health Technol Assess (2003) 9.69
Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet (1995) 9.14
Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ (2001) 8.98
Statistics and ethics in medical research: III How large a sample? Br Med J (1980) 8.78
Better reporting of randomised controlled trials: the CONSORT statement. BMJ (1996) 8.39
More informative abstracts revisited. Ann Intern Med (1990) 8.26
Physical activity assessment methodology in the Five-City Project. Am J Epidemiol (1985) 7.90
Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA (1990) 7.44
Transforming data. BMJ (1996) 6.78
Regression towards the mean. BMJ (1994) 6.57
Community education for cardiovascular health. Lancet (1977) 6.32
Measurement error. BMJ (1996) 6.18
Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol (1985) 6.10
Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA (1994) 5.80
Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion (1999) 5.67
Statistics notes. The odds ratio. BMJ (2000) 5.61
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol (2001) 5.43
Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation (2000) 5.41
Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol (2003) 5.40
How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing. Lancet (1999) 5.27
Statistics notes. Interaction 2: Compare effect sizes not P values. BMJ (1996) 5.18
Correlation, regression, and repeated data. BMJ (1994) 4.88
Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects. BMJ (1995) 4.87
REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer (2005) 4.85
Social factors and height of primary schoolchildren in England and Scotland. J Epidemiol Community Health (1978) 4.73
Randomisation. BMJ (1991) 4.66
Patients' preferences and randomised trials. Lancet (1996) 4.64
Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42
Measurement error and correlation coefficients. BMJ (1996) 4.38
Indirect comparisons of competing interventions. Health Technol Assess (2005) 4.33
The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health (1985) 4.30
Statistical aspects of prognostic factor studies in oncology. Br J Cancer (1994) 4.22
Measurement error. BMJ (1996) 4.13
Survival analysis part I: basic concepts and first analyses. Br J Cancer (2003) 4.08
The Stanford Five-City Project: design and methods. Am J Epidemiol (1985) 4.06
Some examples of regression towards the mean. BMJ (1994) 4.01
Survival probabilities (the Kaplan-Meier method). BMJ (1998) 3.98
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol (2007) 3.84
A catalogue of reporting guidelines for health research. Eur J Clin Invest (2010) 3.83
Seventh graders' self-reported exposure to cigarette marketing and its relationship to their smoking behavior. Am J Public Health (1996) 3.81
Effects of a drug overdose in a television drama on presentations to hospital for self poisoning: time series and questionnaire study. BMJ (1999) 3.52
Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ (2011) 3.50
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Transformations, means, and confidence intervals. BMJ (1996) 3.42
Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ (1995) 3.35
Measurement error proportional to the mean. BMJ (1996) 3.34
National study of health and growth: standards of attained height, weight and triceps skinfold in English children 5 to 11 years old. Ann Hum Biol (1977) 3.23
The use of transformation when comparing two means. BMJ (1996) 3.22
A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med (1990) 3.18
Interaction 3: How to examine heterogeneity. BMJ (1996) 3.17
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer (2004) 3.15
Social class disparities in risk factors for disease: eight-year prevalence patterns by level of education. Prev Med (1990) 3.13
The community-based model of life style intervention trials. Am J Epidemiol (1978) 3.12
Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol (1997) 3.10
Survival analysis part II: multivariate data analysis--an introduction to concepts and methods. Br J Cancer (2003) 3.06
Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects. BMJ (1995) 2.94
Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units. BMJ (1998) 2.94
Indirect measures of cigarette use: expired-air carbon monoxide versus plasma thiocyanate. Prev Med (1984) 2.91
Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA (1996) 2.89
Outcome selection bias in meta-analysis. Stat Methods Med Res (2005) 2.86
Statistics and ethics in medical research. VI--Presentation of results. Br Med J (1980) 2.85
The Behavioral Risk Factor Survey and the Stanford Five-City Project Survey: a comparison of cardiovascular risk behavior estimates. Am J Public Health (1992) 2.80
The effects of combining education and enforcement to reduce tobacco sales to minors. A study of four northern California communities. JAMA (1991) 2.77
A prognostic model for ovarian cancer. Br J Cancer (2001) 2.77
Social marketing and public health intervention. Health Educ Q (1988) 2.72
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Podiatr Med Assoc (2001) 2.71
Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit. Br J Cancer (2003) 2.71
Baseline comparisons in randomized clinical trials. Stat Med (1991) 2.69
Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest (1970) 2.68
Predictors of physician's smoking cessation advice. JAMA (1991) 2.66
Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med (1988) 2.65
Reducing the risk of cardiovascular disease: effects of a community-based campaign on knowledge and behavior. J Community Health (1977) 2.64
The relationship between tobacco access and use among adolescents: a four community study. Soc Sci Med (1999) 2.64
More informative abstracts. Ann Intern Med (1987) 2.63
Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet (2001) 2.61
One and two sided tests of significance. BMJ (1994) 2.61
International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J (1984) 2.50
Prevalence of severe growth hormone deficiency. Br Med J (1977) 2.43